Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2013
07/10/2013CN103191409A Treatment of T-cell mediated diseases
07/10/2013CN103191408A Medicine composition and gel for treating colpitis and applications thereof
07/10/2013CN103191407A Novel use of pentapeptide and metabolite thereof in preparation of anti-dementia product
07/10/2013CN103191406A Application of combination medicine to lymphoma
07/10/2013CN103191405A Combination medicine containing bortezomib
07/10/2013CN103191404A Medicine for treating nose bleeding and preparation method thereof
07/10/2013CN103191403A Method for preparing brain protein hydrolyzate
07/10/2013CN103191070A Oral tablet of superoxide dismutase and preparation method thereof
07/10/2013CN103190941A Combined needling instrument and small molecular minimally invasive technology for curing ankylosing spondylitis
07/10/2013CN102755289B Argatroban injection for resisting thrombus and preparation method thereof
07/10/2013CN102727873B Applications of buckwheat trypsin inhibitor
07/10/2013CN102698247B Glutamine dipeptide and compound amino acid medicinal composition prepared with solvent crystallization method
07/10/2013CN102643762B Brevibacillus parabrevis as well as method and application of protein series prepared thereby
07/10/2013CN102604960B Neurotoxin S10a of South China Sea Conus striatus, coding sequence and application of the neurotoxin
07/10/2013CN102525902B High concentration pidotimod oral liquid
07/10/2013CN102516366B Th1 cell factor immunoregulation polypeptide and application thereof
07/10/2013CN102432670B Silkworm chrysalis protein source dipeptide SS and application thereof
07/10/2013CN102329376B Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof
07/10/2013CN102203118B Peptide antagonist of interleukin-15 activity
07/10/2013CN102060920B Construction of abrin A chain mutant and application as candidate vaccine antigen
07/10/2013CN101816777B Novel Boanmycin composition and preparation method thereof
07/10/2013CN101810560B Cyclosporine A polymeric micelles composition
07/10/2013CN101810559B Hirudin polyion micelle composition of targeted platelet
07/10/2013CN101754768B Survivin peptides as cancer vaccines
07/10/2013CN101721691B Preparation for treating and restoring infective wound surface and preparation method thereof
07/10/2013CN101678086B 固体纤维蛋白原制剂 The solid fibrinogen preparation
07/10/2013CN101643511B Fusion protein for inhibiting telomerase activity, preparation and application thereof
07/10/2013CN101384273B Microrna expression abnormalities in pancreatic endocrine and acinar tumors
07/10/2013CN101107005B CRIg polypeptide for prevention and treatment of complement-associated disorders
07/09/2013US8481686 Antibodies that bind stresscopin peptides
07/09/2013US8481679 Immobilizing an entity in a desired orientation on a support material
07/09/2013US8481676 Protein and production process and use thereof
07/09/2013US8481599 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
07/09/2013US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
07/09/2013US8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
07/09/2013US8481499 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
07/09/2013US8481498 Pharmaceutical compositions and methods
07/09/2013US8481497 Therapeutic agent for cancer, and method for treatment of cancer
07/09/2013US8481496 Gold (III) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
07/09/2013US8481494 Compounds for the treatment of diseases related to protein misfolding
07/09/2013US8481493 Non-porous film for culturing cells
07/09/2013US8481492 Fusion protein and use thereof
07/09/2013US8481491 Scaffold polypeptides for heterologous peptide display
07/09/2013US8481490 Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis
07/09/2013US8481489 GH secretagogues and uses thereof
07/09/2013US8481488 Compositions and methods for reducing the risk of preterm labor
07/09/2013US8481487 Modified soluble FGF receptor Fc fusions method
07/09/2013US8481486 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
07/09/2013US8481485 Insulin analogs
07/09/2013US8481484 Cyclic heptapeptide and use of the same
07/09/2013US8481483 Cyclosporin analogues
07/09/2013US8481482 Prion protein based hemin binders and methods of use
07/09/2013US8481481 Peptides and their use as carriers into cancer cells
07/09/2013US8481480 Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol
07/09/2013US8481479 Formulations of factor VIIa inhibitors and utility
07/09/2013US8481478 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
07/09/2013US8481333 Detection of degradation products of feline NT-proBNP
07/09/2013US8481255 Scytovirin domain 1 related polypeptides
07/09/2013US8481089 Topical skin care formulations comprising plant extracts
07/09/2013US8481076 Bariatric magnetic apparatus and method of manufacturing thereof
07/09/2013US8481070 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
07/09/2013US8481064 Method for delivering a therapeutic agent comprising injection of microspheres
07/09/2013US8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
07/09/2013US8481049 Methods for treating a wound using epidermal growth factor formulation
07/09/2013US8481046 VEGF antagonist formulations for intravitreal administration
07/09/2013US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
07/09/2013US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
07/09/2013US8481031 Methods and compositions using Klotho-FGF fusion polypeptides
07/09/2013US8481022 Method of treating autoimmune disease with mesenchymal stem cells
07/09/2013US8481021 IL-1F5 polypeptides
07/09/2013US8481003 Anti-CD74 immunoconjugates and methods
07/09/2013CA2648936C Glp-1 compounds
07/09/2013CA2640994C Enamel matrix protein composition for preventing or treating infection
07/09/2013CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties
07/09/2013CA2558583C Polymer-based compositions and conjugates of hiv entry inhibitors
07/09/2013CA2556917C Process for preparing macrocyclic compounds
07/09/2013CA2541840C P185neu-encoding dna and therapeutical uses thereof
07/09/2013CA2537290C Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
07/09/2013CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
07/09/2013CA2532742C Use of a pak inhibitor for the treatment of a joint disease
07/09/2013CA2527039C Grf analog compositions and their use
07/09/2013CA2524403C Active variants of the il-18 binding protein and medical uses thereof
07/09/2013CA2512824C Improved oral delivery of peptides
07/09/2013CA2511530C Night-time oral insulin therapy
07/09/2013CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12)
07/09/2013CA2463641C Antisense antiviral agent and method for treating ssrna viral infection
07/09/2013CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
07/09/2013CA2369413C Transmembrane protein expressed in prostate and other cancers
07/09/2013CA2354188C Cancer cell vaccine
07/09/2013CA2349468C Factor viii polypeptide having factor viii:c activity
07/06/2013CA2801540A1 Insulin receptor induced elastin production
07/05/2013CA2800946A1 Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same
07/04/2013WO2013102211A2 Stabilized antiviral fusion helices
07/04/2013WO2013102209A1 Glypican-4 based compositions and methods for treating and diagnosing insulin resistance
07/04/2013WO2013102144A2 Ph20 polypeptede variants, formulations and uses thereof
07/04/2013WO2013102063A1 Endopeptidase and neurotoxin combination treatment of bladder disorders
07/04/2013WO2013102047A1 Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
07/04/2013WO2013101749A1 Stabilized glucagon nanoemulsions
07/04/2013WO2013101724A2 Inhibition of clostridium difficile toxins
07/04/2013WO2013101645A1 Compositions and methods for regulating glucose metabolism